{
    "clinical_study": {
        "@rank": "151232", 
        "arm_group": {
            "arm_group_label": "Orfadin suspension", 
            "arm_group_type": "Experimental", 
            "description": "Drug: nitisinone, oral suspension"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to verify that pediatric patients, especially those who are not\n      old enough to swallow capsules, accept the taste and palatability of a new suspension."
        }, 
        "brief_title": "Taste and Palatability of Orfadin Suspension", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                        "title": "Orfadin Suspension"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "18"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "18"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "5.60", 
                                            "@value": "8.03"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "9"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "9"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "France"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "4"
                                            }
                                        }, 
                                        "sub_title": "Germany"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "12"
                                            }
                                        }, 
                                        "sub_title": "United Kingdom"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The results are intended to be published as a whole. If no comprehensive publication appears within 12 months of the trial termination, Investigators have the right to publish their results. Such data to be submitted to the Sponsor for review at least 60 days prior to submission for publication, public dissemination, or review by a publication committee. The Sponsor shall be entitled to make a reasoned request that publication be delayed for a period of up to 6 months."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Patients rated the taste of the suspension. The following grading was applied: 5 (very good taste), 4 (good taste), 3 (neither good nor bad taste), 2 (bad taste) and 1 (very bad taste).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                                "title": "Age 5-<18 Years"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "12"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "2.0", 
                                                    "@upper_limit": "5.0", 
                                                    "@value": "4.0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Patients rated the taste of the suspension. The following grading was applied: 5 (very good taste), 4 (good taste), 3 (neither good nor bad taste), 2 (bad taste) and 1 (very bad taste).", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "The Taste Score for the Last Dose of the Suspension on Day 3 for Subjects 5 - <18 Years", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Full analysis set: All subjects who received at least one dose of study drug and had at least one taste or acceptability assessments", 
                        "safety_issue": "No", 
                        "time_frame": "Day 3", 
                        "title": "The Taste Score for the Last Dose of the Suspension on Day 3 for Subjects 5 - <18 Years", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "The parents of patients aged <5 years rated their child\u00b4s acceptability of the suspension. The following grading was applied: 5 (very well), 4 (well), 3 (neither well nor badly), 2 (badly) and 1 (very badly).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                                "title": "Age <5 Years"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "4.0", 
                                                    "@upper_limit": "5.0", 
                                                    "@value": "5.0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "The parents of patients aged <5 years rated their child\u00b4s acceptability of the suspension. The following grading was applied: 5 (very well), 4 (well), 3 (neither well nor badly), 2 (badly) and 1 (very badly).", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "The Acceptability Score for the Last Dose of the Suspension on Day 3 for Subjects < 5 Years", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Full analysis set: All subjects who received at least one dose of study drug and had at least one taste or acceptability assessments", 
                        "safety_issue": "No", 
                        "time_frame": "Day 3", 
                        "title": "The Acceptability Score for the Last Dose of the Suspension on Day 3 for Subjects < 5 Years", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                                "title": "Age 5-<18 Years"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "12"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "3.0", 
                                                    "@upper_limit": "5.0", 
                                                    "@value": "4.0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "The Palatability Scores on Day 1 (Subjects 5 - < 18 Years)", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Full analysis set: All subjects who received at least one dose of study drug and had at least taste or acceptability assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1", 
                        "title": "The Palatability Scores on Day 1 (Subjects 5 - < 18 Years)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                                "title": "Age 5-<18 Years"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "12"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "2.0", 
                                                    "@upper_limit": "5.0", 
                                                    "@value": "4.0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "The Palatability Scores on Day 2 (Subjects 5 - < 18 Years)", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Full analysis set: All subjects who received at least one dose of study drug and had at least taste or acceptability assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 2", 
                        "title": "The Palatability Scores on Day 2 (Subjects 5 - < 18 Years)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                                "title": "Age 5-<18 Years"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "12"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "2.0", 
                                                    "@upper_limit": "5.0", 
                                                    "@value": "4.0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "The Palatability Scores on Day 3 (Subjects 5 - < 18 Years)", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Full analysis set: All subjects who received at least one dose of study drug and had at least taste or acceptability assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 3", 
                        "title": "The Palatability Scores on Day 3 (Subjects 5 - < 18 Years)", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                        "title": "Orfadin Suspension"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "18", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "18", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "recruitment_details": "The study recruitment was performed at seven medical clinics in three countries (United Kingdom, Germany and France). First subject was enrolled on 09 November 2012 and last subject\u00b4s last visit was on 01 March 2013."
            }, 
            "point_of_contact": {
                "email": "erik.brouwer@sobi.com", 
                "name_or_title": "Medical Director", 
                "organization": "Swedish Orphan Biovitrum", 
                "phone": "+46 8 697 20 00"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Drug: nitisinone, oral suspension 4 mg/mL, twice daily dosing, total daily dose according to current prescribed dose at screening", 
                        "title": "Orfadin Suspension"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "18"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "18"
                                            }, 
                                            "sub_title": "Regurgitation"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "18"
                                            }, 
                                            "sub_title": "Diarrhoea"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "18"
                                            }, 
                                            "sub_title": "Mouth haemorrhage"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "18"
                                        }, 
                                        "sub_title": "Pyrexia"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "18"
                                        }, 
                                        "sub_title": "Nasopharyngitis"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 15.1", 
                    "frequency_threshold": "0"
                }, 
                "time_frame": "Adverse events were recorded upon administration of first dose until last study visit 1 week after last dose. Serious Adverse Events were recorded from subject signed informed consent until 28 days after last dose."
            }
        }, 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Hereditary Tyrosinemia Type 1 (HT-1)", 
        "condition_browse": {
            "mesh_term": "Tyrosinemias"
        }, 
        "detailed_description": {
            "textblock": "This is an open, non-randomized, non-controlled, multiple-dose study in 18 pediatric\n      patients. The treatment period is three days, and during the study the subjects will rate\n      the taste and palatability of the suspension or (for younger children) their parents will\n      rate the child\u00b4s acceptance of the suspension.\n\n      The study consists of a screening period, a 3 day treatment period and a 1 week follow-up\n      period."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with HT-1 currently managed on Orfadin (nitisinone) capsules.\n\n          -  Age from 1 month to less than 18 years.\n\n          -  Signed informed consent.\n\n        Exclusion Criteria:\n\n          -  Any medical condition which in the opinion of the investigator makes the subject\n             unsuitable for inclusion.\n\n          -  Enrollment in another concurrent clinical study, or intake of an investigational\n             medicinal product (IMP), within one month prior to inclusion in this study.\n\n          -  Foreseeable inability to cooperate with given instructions or study procedures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "1 Month"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 22, 2012", 
        "firstreceived_results_date": "January 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01734889", 
            "org_study_id": "Sobi.NTBC-002"
        }, 
        "intervention": {
            "arm_group_label": "Orfadin suspension", 
            "description": "Oral suspension", 
            "intervention_name": "Nitisinone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Nitisinone"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "nitisinone", 
            "Orfadin", 
            "suspension", 
            "taste", 
            "acceptability"
        ], 
        "lastchanged_date": "March 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Hopital Necker"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "D\u00fcsseldorf", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum D\u00fcsseldorf"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum Heidelberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum der Universit\u00e4t M\u00fcnchen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Birmingham Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Evelina Children's Hospital, St Thomas' Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "St Mary's Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Taste and Palatability of Orfadin Suspension. An Open, Non-controlled 3 Day Study in Pediatric Patients With Hereditary Tyrosinemia Type 1 Treated With Orfadin.", 
        "overall_official": {
            "affiliation": "Swedish Orphan Biovitrum", 
            "last_name": "Erik Brouwer, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Patients rated the taste of the suspension. The following grading was applied: 5 (very good taste), 4 (good taste), 3 (neither good nor bad taste), 2 (bad taste) and 1 (very bad taste).", 
                "measure": "The Taste Score for the Last Dose of the Suspension on Day 3 for Subjects 5 - <18 Years", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }, 
            {
                "description": "The parents of patients aged <5 years rated their child\u00b4s acceptability of the suspension. The following grading was applied: 5 (very well), 4 (well), 3 (neither well nor badly), 2 (badly) and 1 (very badly).", 
                "measure": "The Acceptability Score for the Last Dose of the Suspension on Day 3 for Subjects < 5 Years", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01734889"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                "measure": "The Palatability Scores on Day 1 (Subjects 5 - < 18 Years)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                "measure": "The Palatability Scores on Day 2 (Subjects 5 - < 18 Years)", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "Patients rated the palatability of the suspension. The following grading was applied: 5 (very good), 4 (good), 3 (neither good nor bad), 2 (bad) and 1 (very bad).", 
                "measure": "The Palatability Scores on Day 3 (Subjects 5 - < 18 Years)", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }
        ], 
        "source": "Swedish Orphan Biovitrum", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Swedish Orphan Biovitrum", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}